MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Revenue
$247,221K
Net Income
-$20,942K
Net Profit Margin
-8.47%
EPS
-$0.3
Unit: Thousand (K) dollars
Revenue Breakdown
    • US
    • Non Us

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Sales
247,221 290,383 249,253 240,678
Cost of sales
110,433 122,923 114,961 114,823
Gross profit
136,788 167,460 134,292 125,855
Selling, general and administrative
108,187 113,100 108,440 109,596
Litigation and settlement expense
NaN 0 0 19,951
Research and development
46,035 46,066 48,715 48,118
Acquired in-process research and development expenses
0 0 0 0
Total operating expenses
154,222 159,166 157,155 177,665
Loss on extinguishment of debt
NaN 0* 0 0
Operating gain
-17,434 8,294 -22,863 -51,810
Interest income and other income, net
3,626 3,016* 2,509 -632
Interest expense
2,204 2,075 2,065 1,905
Loss from equity method investments
-3,865 -4,553 -2,724 -3,375
Total other income (expense), net
-2,443 -3,612 -2,280 -5,912
Income Gain From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
-19,900 4,639 -25,100 -57,722
Income Tax Expense Benefit
516 5,293 -4,000 -5,322
Net loss
-20,393 -589 -21,165 -52,400
Unrealized gain (loss) on short-term investments
-1,027 -88* 241 -98
Unrealized gain on cash flow hedges
1,702 -195* 534 -612
Foreign currency translation gains (losses)
-1,224 708 648 4,380
Comprehensive loss
-20,942 -164 -19,742 -48,730
Basic EPS
-0.3 -0.002 -0.31 -0.78
Diluted EPS
-0.3 -0.002 -0.31 -0.78
Basic Average Shares
68,397,000 68,034,000 67,652,000 67,050,000
Diluted Average Shares
68,397,000 68,034,000 67,652,000 67,050,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Comprehensive loss-$20,942K (83.71%↑ Y/Y)Unrealized gain on cash flowhedges$1,702K Net loss-$20,393K (84.38%↑ Y/Y)Foreign currencytranslation gains (losses)-$1,224K (-176.55%↓ Y/Y)Unrealized gain (loss) onshort-term investments-$1,027K (-342.79%↓ Y/Y)US$160,843K (6.78%↑ Y/Y)Non Us$86,378K (3.09%↑ Y/Y)Income Gain FromContinuing Operations...-$19,900K (83.70%↑ Y/Y)Income Tax ExpenseBenefit$516K (-93.91%↓ Y/Y)Sales$247,221K (5.46%↑ Y/Y)Operating gain-$17,434K (85.58%↑ Y/Y)Total other income(expense), net-$2,443K (-101.73%↓ Y/Y)Gross profit$136,788K (15.52%↑ Y/Y)Interest income and otherincome, net$3,626K Cost of sales$110,433K (-4.81%↓ Y/Y)Total operatingexpenses$154,222K (-35.55%↓ Y/Y)Loss from equitymethod investments-$3,865K (-9.12%↓ Y/Y)Interest expense$2,204K (18.37%↑ Y/Y)Selling, general andadministrative$108,187K (-4.98%↓ Y/Y)Research and development$46,035K (-8.32%↓ Y/Y)

TANDEM DIABETES CARE INC (TNDM)

TANDEM DIABETES CARE INC (TNDM)